#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mastocytosis Prodromal Alzheimer's disease Ovarian epithelial cancer Rheumatoid arthritis Dent's disease Hereditary motor and sensory neuropathy Primary amyloidosis Pancreatic carcinoma T-cell lymphoma Acute promyelocytic leukaemia B-cell small lymphocytic lymphoma Neurofibromatosis Mantle cell lymphoma stage IV Ataxia telangiectasia Hypocalcaemia More trials…

    Learn about Rare Diseases

    Optic glioma – Life with Disease Marginal zone lymphoma – Basic Information Phenylketonuria – Basic Information Burkitt’s lymphoma – Life with Disease Antisynthetase syndrome – Life with Disease Breast angiosarcoma – Life with Disease Adrenocortical carcinoma – Basic Information Aicardi-Goutieres syndrome – Treatment Pleural mesothelioma malignant – Diagnostics Haemophilia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluorodopa (18F) Fosfomycin Trometamol Mitotane Varegacestat Cpk850 Filgotinib Fondaparinux Sodium Aceclofenac Doxycycline Toldc Etoricoxib Romosozumab Edg-5506 Paraffin White Soft Dacarbazine CIRTUVIVINT Treprostinil Bay 3283142 Pritelivir Pantothenate Sodium More therapies…

    Learn about Your Condition

    Bronchopulmonary aspergillosis Drug dependence Mucopolysaccharidosis Supraventricular tachycardia Anal incontinence Periodontitis Psychogenic seizure Cutaneous calcification Carcinoid tumour pulmonary Tertiary adrenal insufficiency Tardive dyskinesia Guttate psoriasis Giardiasis Vertebrobasilar stroke Osteogenesis imperfecta More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 2 diabetes mellitus

  • Study on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Glimepiride
    • Glipizide
    Poland

  • Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Austria Czechia Greece The Netherlands Portugal Romania

  • Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteopenia
    • Osteoporosis
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Alendronate Sodium Monohydrate
    Denmark

  • Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Metformin
    • Dapagliflozin
    Bulgaria Hungary Latvia Lithuania Poland

  • Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Czechia Germany Greece

  • Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Insulin Glargine
    • Insulin Icodec
    • Metformin
    Greece Italy Poland
Previous Page
1 … 9 10 11 12 13
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!